Investments & Funding

This new hospital, with 120 beds, offers a comprehensive range of services, including outpatient care, emergency treatment, and specialised medical attention.

This dedicated facility is designed to provide fast, general practitioner (GP)-led care for patients with urgent but non-life-threatening medical issues.

This decision is aimed at ensuring the swift and efficient delivery of Novo Nordisk’s promised investment of over 2 billion euros (US$2.34 billion) in a manufacturing facility located south of Rome.

The grant, with a total funding of AED 3 million (US$817,000), invites global researchers to submit proposals focusing on innovation, evidence-based methods, and interdisciplinary collaboration.

These new therapies aim to offer more effective and innovative options for individuals seeking mental health and neurological support.

The expansion project is designed to enhance healthcare quality by establishing specialized clinics equipped with modern medical devices and comfortable office furnishings.

This partnership aims to open new opportunities in medical tourism and specialized care, with a special focus on supporting oncology patients through expert skin health services.

This new lab represents a significant advancement for GMU, as it aims to enhance the university’s existing artificial intelligence programs by providing a modern, interactive space for learning and research.

The deal, valued at approximately Rs. 25,689 crore (US$3.01 billion), will be executed in two phases and will culminate in the merger of the two companies to create a diversified healthcare platform.

Hikma has been operating in the US since 1991 and has invested over US$4 billion in the past 15 years to build and enhance its US-based manufacturing and R&D facilities.